Back

Fibrinolysis as therapeutic target in myocardial infarction.

1 September 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Thrombosis, Coagulation and Cardiovascular Risk Basic Science, Other ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Diana A Gorog

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Thromboinflammation and vascular disease.
Professor P. Wenzel (Mainz, DE)
Slides Video
Presentation thumbnail
Pleiotropic effects of anti-thrombotic therapies in cardiovascular prevention.
Professor H. Ten Cate (Maastricht, NL)
Slides Video

Access the full session

Session thumbnail
Thrombosis, Coagulation and Cardiovascular Risk

The Event

Event poster

ESC Congress 2020

1 September 2020 08:30 CET
You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodelling after acute myocardial infarction - Results of the CHIARA MIA 2 trial
31 August 2019
thumbnail
Congress Presentation
Differences in mortality between patients with cardiogenic shock due to STEMI treated with PCI vs thrombolysis
9 March 2024
thumbnail
Congress Presentation
Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources